Skip to content

Telemedicine Versus Face-to-face Follow-Up in Post-AKI survivors, A Randomized Controlled Trial

Telemedicine Versus Face to face Follow-Up in Post-AKI survivors, A Randomized Controlled Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240928002
Enrollment
56
Registered
2024-09-28
Start date
2024-09-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-AKI stage 2-3 survivors Post-AKI, telemedicine, AKI, follow-up care

Interventions

Post-AKI survivors will be screening and randomization at first visit: 2-4 week after discharge. In the Telemedicine group, the patients will be follow-up by TU telemed application for 2 visit (3 and
Experimental Other,Active Comparator Other
Telemedicine,Face to Face

Sponsors

Thammasat University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Post AKI stage 2-3 patients 2. Age more than 18 years old 3. Require Telemedicine application

Exclusion criteria

Exclusion criteria: 1. End stage renal disease (eGFR < 15 mL/min/1.73m2) 2. Dialysis dependent after AKI episode 3. Baseline SCr < 0.5 mg/dL 4. Dementia or cognitive function impairment or fraily status or life expantecy < 3 months.

Design outcomes

Primary

MeasureTime frame
Feasibility outcomes - Renal function measurement 6 months Serum creatinine,Feasibility outcomes - Blood pressure measurement 6 months Blood pressure,Feasibility outcomes - Loss follow-up rate 6 months Follow up

Secondary

MeasureTime frame
Patients' satisfraction 6 months Scale,Rate of recovery AKI 6 months Rate of recovery AKI,Major adverse kidney events 6 months Serum creatinine, mortality,Rate of recurrent AKI 6 months Serum creatinine,Travel cost 6 months Cost (TH Baht)

Countries

Thailand

Contacts

Public ContactPeerapat Thanapongsatorn

Thammasat University Hospital

peerapat@tu.ac.th029269999

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026